Spinal Cord Injury clinical trials at UCSD

1 research study open to eligible people

Showing trials for

  • Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury

    open to eligible people ages 18-65

    The DOSED clinical study evaluates the safety and utility of a novel delivery device to deliver LCTOPC1, a cell therapy, to the spinal cord of patients with a spinal cord injury (SCI). LCTOPC1 is designed to replace or support cells that are absent or dysfunctional due to traumatic injury, with a goal to help improve the quality of life and restore or augment functional activity in persons suffering from a traumatic cervical or thoracic injuries.

    La Jolla, California

Our lead scientists for Spinal Cord Injury research studies include .

Last updated: